Test-retest precision and longitudinal cartilage thickness loss in the IMI-APPROACH cohort
Wirth, Wolfgang; Maschek, Susanne; Marijnissen, Anne C A; Lalande, Agnes; Blanco, Francisco J; Berenbaum, Francis; van de Stadt, Lotte A; Kloppenburg, Margreet; Haugen, Ida K; Ladel, Christoph H; Bacardit, Jaume; Wisser, Anna; Eckstein, Felix; Roemer, Frank W; Lafeber, Floris P J G; Weinans, Harrie H; Jansen, Mylène
(2023) Osteoarthritis and Cartilage, volume 31, issue 2, pp. 238 - 248
(Article)
Abstract
Objective: To investigate the test–retest precision and to report the longitudinal change in cartilage thickness, the percentage of knees with progression and the predictive value of the machine-learning-estimated structural progression score (s-score) for cartilage thickness loss in the IMI-APPROACH cohort – an exploratory, 5-center, 2-year prospective follow-up cohort. Design: Quantitative
... read more
cartilage morphology at baseline and at least one follow-up visit was available for 270 of the 297 IMI-APPROACH participants (78% females, age: 66.4 ± 7.1 years, body mass index (BMI): 28.1 ± 5.3 kg/m 2, 55% with radiographic knee osteoarthritis (OA)) from 1.5T or 3T MRI. Test–retest precision (root mean square coefficient of variation) was assessed from 34 participants. To define progressor knees, smallest detectable change (SDC) thresholds were computed from 11 participants with longitudinal test–retest scans. Binary logistic regression was used to evaluate the odds of progression in femorotibial cartilage thickness (threshold: −211 μm) for the quartile with the highest vs the quartile with the lowest s-scores. Results: The test–retest precision was 69 μm for the entire femorotibial joint. Over 24 months, mean cartilage thickness loss in the entire femorotibial joint reached −174 μm (95% CI: [−207, −141] μm, 32.7% with progression). The s-score was not associated with 24-month progression rates by MRI (OR: 1.30, 95% CI: [0.52, 3.28]). Conclusion: IMI-APPROACH successfully enrolled participants with substantial cartilage thickness loss, although the machine-learning-estimated s-score was not observed to be predictive of cartilage thickness loss. IMI-APPROACH data will be used in subsequent analyses to evaluate the impact of clinical, imaging, biomechanical and biochemical biomarkers on cartilage thickness loss and to refine the machine-learning-based s-score. Clinicaltrials.gov identification: NCT03883568.
show less
Download/Full Text
Keywords: Cartilage loss, Knee, MRI, Osteoarthritis, Progression, Test–retest precision, Biomedical Engineering, Rheumatology, Orthopedics and Sports Medicine, Journal Article
ISSN: 1063-4584
Publisher: W.B. Saunders Ltd
Note: Funding Information: The research leading to these results have received support from the Innovative Medicines Initiative Joint Undertaking under Grant Agreement no 115770 , resources of which are composed of financial contribution from the European Union's Seventh Framework Programme ( FP7/2007-2013 ) and EFPIA companies' in kind contribution. See www.imi.europa.eu and www.approachproject.eu . The authors would like to thank the IMI-APPROACH participants and the staff at each of the clinical centers. Funding Information: •Felix Eckstein: CEO and shareholder of Chondrometrics GmbH and received personal fees from AbbVie , Galapagos NV , HealthLink , ICM , IRIS , Kolon TissueGene , Merck KGaA , Novartis , Roche and Samumed and grants from Foundation for the NIH , University of California, San Francisco , NIH/ National Heart, Lung, and Blood Institute , Bioclinica , Galapagos NV , Novartis , TissueGene , Erlangen University Hospital , University of Sydney , CALIBR , University of Basel , University of Western Ontario , Stanford University , ICM Co., Ltd. , UMC Utrecht , Federal Ministry of Education and Research , Germany. Publisher Copyright: © 2022 The Author(s)
(Peer reviewed)